Sandoz Expands Recall of Cefazolin Vials Over Labeling Error

1 min read
Source: fda.gov
Sandoz Expands Recall of Cefazolin Vials Over Labeling Error
Photo: fda.gov
TL;DR Summary

Sandoz has expanded a nationwide recall of one lot of Cefazolin for Injection after discovering some vials were mislabeled as Penicillin G Potassium, which could pose serious health risks if administered. No adverse events have been reported, but the company is urging healthcare providers and customers to stop using the affected product and return it.

Share this article

Reading Insights

Total Reads

0

Unique Readers

1

Time Saved

5 min

vs 6 min read

Condensed

95%

1,09355 words

Want the full story? Read the original article

Read on fda.gov